These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30269300)

  • 1. Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.
    Koga Y; Povalko N; Inoue E; Nakamura H; Ishii A; Suzuki Y; Yoneda M; Kanda F; Kubota M; Okada H; Fujii K
    J Neurol; 2018 Dec; 265(12):2861-2874. PubMed ID: 30269300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
    Ikawa M; Povalko N; Koga Y
    Curr Opin Clin Nutr Metab Care; 2020 Jan; 23(1):17-22. PubMed ID: 31693521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-arginine improves the symptoms of strokelike episodes in MELAS.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Tanabe Y; Fujimoto S; Matsuishi T
    Neurology; 2005 Feb; 64(4):710-2. PubMed ID: 15728297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the critical time point for efficacy of L-arginine infusion therapy in a case of MELAS with frequent stroke-like episodes].
    Sudo A; Sano H; Kawamura N
    No To Hattatsu; 2014 Jan; 46(1):39-43. PubMed ID: 24620430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [L-arginine therapy on MELAS].
    Koga Y
    Rinsho Shinkeigaku; 2008 Nov; 48(11):1010-2. PubMed ID: 19198147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
    Lekoubou A; Kouamé-Assouan AE; Cho TH; Luauté J; Nighoghossian N; Derex L
    Rev Neurol (Paris); 2011 Nov; 167(11):852-5. PubMed ID: 21514942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome.
    Rodan LH; Poublanc J; Fisher JA; Sobczyk O; Mikulis DJ; Tein I
    PLoS One; 2020; 15(9):e0238224. PubMed ID: 32881886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
    Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
    Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of midazolam for L-arginine-resistant headaches during stroke-like episodes in MELAS: a case report].
    Tsujikawa K; Yokoi S; Yasui K; Hasegawa Y; Hoshiyama M; Yanagi T
    Rinsho Shinkeigaku; 2014; 54(11):882-7. PubMed ID: 25420561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of L-arginine for stroke-like episode in MELAS.
    Kubota M; Sakakihara Y; Mori M; Yamagata T; Momoi-Yoshida M
    Brain Dev; 2004 Oct; 26(7):481-3; discussion 480. PubMed ID: 15351086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.
    Rodan LH; Wells GD; Banks L; Thompson S; Schneiderman JE; Tein I
    PLoS One; 2015; 10(5):e0127066. PubMed ID: 25993630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of MELAS and L-arginine effects.
    Koga Y; Povalko N; Nishioka J; Katayama K; Yatsuga S; Matsuishi T
    Biochim Biophys Acta; 2012 May; 1820(5):608-14. PubMed ID: 21944974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELAS and L-arginine therapy.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
    Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation.
    Shigemi R; Fukuda M; Suzuki Y; Morimoto T; Ishii E
    Brain Dev; 2011 Jun; 33(6):518-20. PubMed ID: 20832210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients.
    Yoneda M; Ikawa M; Arakawa K; Kudo T; Kimura H; Fujibayashi Y; Okazawa H
    Biochim Biophys Acta; 2012 May; 1820(5):615-8. PubMed ID: 21600268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [l-arginine efficiency in MELAS syndrome. A case report].
    Moutaouakil F; El Otmani H; Fadel H; Sefrioui F; Slassi I
    Rev Neurol (Paris); 2009 May; 165(5):482-5. PubMed ID: 18849057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MELAS: a nationwide prospective cohort study of 96 patients in Japan.
    Yatsuga S; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T; Kakuma T; Koga Y;
    Biochim Biophys Acta; 2012 May; 1820(5):619-24. PubMed ID: 21443929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.
    Ganetzky RD; Falk MJ
    Mol Genet Metab; 2018 Mar; 123(3):301-308. PubMed ID: 29428506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELAS: Monitoring treatment with magnetic resonance spectroscopy.
    Hovsepian DA; Galati A; Chong RA; Mazumder R; DeGiorgio CM; Mishra S; Yim C
    Acta Neurol Scand; 2019 Jan; 139(1):82-85. PubMed ID: 30216413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of L-arginine infusion for status epilepticus in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes].
    Toribe Y; Tominaga K; Ogawa K; Suzuki Y
    No To Hattatsu; 2007 Jan; 39(1):38-43. PubMed ID: 17228817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.